Greenway Greenhouse’s New International Supply Agreement
Greenway Greenhouse Cannabis Corporation (CSE: GWAY, OTCQB: GWAYF) is proud to announce a significant international supply agreement with 4C LABS, a prominent medical cannabis firm focused on enhancing patient care through top-tier cannabis products.
Strategic Partnership with 4C LABS
This collaboration aims to deliver high-quality dried cannabis flower to 4C LABS, a leader in importing and distributing cannabis-based pharmaceuticals. Greenway's expertise aligns with 4C's commitment to providing superior medical cannabis to patients seeking effective solutions.
Market Expansion Potential
Across the globe, the demand for high-quality cannabis products is rapidly increasing. Greenway is actively engaging with international partners to tap into these burgeoning markets. As President Carl Mastronardi stated, Canadian cannabis is recognized for its exceptional quality and safety, setting a gold standard worldwide.
Commitment to Quality
Carl emphasized how partnering with global distributors like 4C LABS could open doors to markets that promise improved profit margins compared to the competitive Canadian market. Greenway's focus remains on providing the highest quality products, ensuring they are in line with the unique needs of international patients.
4C LABS’ Perspective
Greg Dobbin, CEO of 4C LABS, shared his enthusiasm for incorporating Greenway into their product line, highlighting Greenway's reputation as a premier medical cannabis cultivator with decades of experience. He expressed confidence that patients in the UK would greatly appreciate the quality of Greenway's offerings.
Issuance of Shares and Corporate Growth
Additionally, Greenway recently issued 337,507 common shares as part of its engagement with Abingdon Capital Corporation. These shares were deemed between $0.20 and $0.29 and are part of the company’s strategy to augment its corporate finance advisory services. This growth in shares reflects Greenway’s dedication to maintaining operational excellence.
About Greenway
Greenway Greenhouse Cannabis Corporation is a licensed cannabis cultivator renowned for its commitment to quality in the Canadian cannabis industry. With a strong foundation in agriculture intertwined with cannabis cultivation, Greenway aims to be a leading force in this evolving market. For further details, investors can explore updates on Greenway's various social media platforms.
About 4C LABS
4C LABS is committed to making world-class medical cannabis accessible to UK pharmacies and patients. Holding import and distribution licenses across the UK and beyond, they focus on providing patients with trusted cannabis solutions at valuable prices, ensuring that their product line meets high industry standards.
Frequently Asked Questions
What is the purpose of the agreement between Greenway and 4C LABS?
The agreement focuses on supplying high-quality cannabis products to 4C LABS for distribution in the UK, enhancing patient care.
How does this agreement affect Greenway's market presence?
The partnership allows Greenway to expand its reach internationally, tapping into emerging markets and potentially increasing profit margins.
What distinguishes Greenway's cannabis from competitors?
Greenway is known for its commitment to quality, safety, and sustainability in cannabis cultivation, making it a reliable choice for medical use.
What can patients expect from 4C LABS' new offerings?
Patients can anticipate premium medical cannabis products that meet stringent quality standards, thanks to this collaboration.
Where can investors learn more about Greenway's activities?
Investors can visit Greenway's website or follow its updates on social media for the latest news and developments.
